世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

動物用腸内環境の市場：添加物（プロバイオティクス、プレバイオティクス、フィトジェニック、免疫賦活剤）、家畜（家禽、豚、反芻動物、養殖）、形態（乾燥、液体）、供給元、地域別 - 2027年までの世界予測


Animal Intestinal Health Market by Additive (Probiotics, Prebiotics, Phytogenics, Immunostimulants), Livestock (Poultry, Swine, Ruminant, Aquaculture), Form (Dry, Liquid), Source, Region - Global Forecast to 2027

2022年に37億米ドルと推定される動物腸管衛生市場は、2022年から2027年にかけて年平均成長率8.2%で54億米ドルに成長すると予測されています。飼料添加物は、動物が摂取する通常の食事に栄養価を与えるものです。... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2022年7月12日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		223 228 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

2022年に37億米ドルと推定される動物腸管衛生市場は、2022年から2027年にかけて年平均成長率8.2%で54億米ドルに成長すると予測されています。飼料添加物は、動物が摂取する通常の食事に栄養価を与えるものです。人口の増加に伴い、動物の腸内飼料製品も需要の急増を目の当たりにしています。飼料製品の需要増に対応するため、メーカーはプロバイオティクス、プレバイオティクス、フィトジェニック飼料添加物、その他の飼料添加物を活用して、家畜の腸内環境と生産性を高めることに注力しています。肉や乳製品に対する意識の高まり、家畜に関連する健康への懸念、動物加工製品の工業化の進展などが、動物腸管健康市場の世界的な成長を促す主な要因となっています。政府機関による抗生物質の使用に関する規制の実施に伴い、腸内健康を改善するための天然飼料添加物の需要は今後も高く維持されると予想されます。


"欧州は2番目に成長の早い地域で、予測期間中に数量ベースで7.62%の成長を目撃すると予測されています。"
ヨーロッパの飼料産業は、世界レベルで見ても最大の飼料生産市場の一つです。ヨーロッパの飼料生産者は、家畜のパフォーマンスを向上させるための高品質な飼料製品の需要増加に対応するため、プロバイオティクス、プレバイオティクス、フィトジェニック、免疫賦活剤に基づく様々な飼料添加物を使用しています。この地域のさまざまな飼料メーカーは、家畜のパフォーマンスを向上させるマンナンオリゴ糖やフラクトオリゴ糖などのプレバイオティクスを含めることに重点を置くようになりました。ヨーロッパの飼料生産者は、豚の飼料生産に使用される飼料用抗生物質の代替品として、エッセンシャルオイルなどのフィトジェニックの使用を好んでいます。これらのフィトジェニックは主要な飼料添加物として機能し、飼料摂取量の増加や家畜の腸内機能の改善に役立ちます。
"予測期間中、微生物セグメントがより大きな市場シェアを占めた"
微生物を利用して製造された飼料添加物の増加により、予測期間中、微生物セグメントがより大きな市場シェアを占めました。プロバイオティクスは、豚、反芻動物、家禽などの家畜種において、体重増加、飼料製品の消化率向上、腸内細菌叢全体の強化に役立つとされています。しかし、微生物由来の代替品に関するさまざまな認識が広まるにつれ、フィトジェニックや特定のプレバイオティクスなど、植物由来の腸内健康素材が人気を博しています。
"乾燥形態セグメントが2022年の金額ベースで市場全体の73.64%のシェアを占め、市場を支配しています。"
乾燥した動物用腸内環境改善製品は、液体のものよりも比較的安価であるため、飼料メーカーに好まれています。また、異なる添加物を粉末状にすることで混合が容易になります。乾燥形態は保存期間が長く、輸送も簡単です。これらのことから、飼料メーカーや給餌業者の間で好まれています。


プライマリーの内訳
企業タイプ別Tier1：60.0%、Tier2：25.0%、Tier3：15.0%。
役職別役職別：マネージャー 45.0％、CXO 35.0％、エグゼクティブ 20.0
地域別欧州45％、北米10％、アジア太平洋25％、南米5％、アジア太平洋地域15％。

本レポートに掲載されている主要なプレイヤー
1.カーギル社 (米国)
2.Koninklijke DSM N.V.(オランダ)
3.アーチャー・ダニエルズ・ミッドランド社（米国）
4.デュポン株式会社（米国）
5.エボニックインダストリーズ（ドイツ）
6.ノボザイムズ（デンマーク）
7.ニュートレコ（オランダ）
8.Chr.Hansenホールディングス(デンマーク)
9.ブルースター・アディッセオ・ピーブイティーイー・リミテッド(中国)です。
10.オールテック(米国)
11.エボニックインダストリーズ(ドイツ)
12.ラレマンド社（カナダ）
13.ビオリジン（ブラジル）
14.ランドアンドオレイクス社（米国）
15.レザフレ（フランス）
16.カルピス株式会社(日本)
17.ABビスタ（イギリス）
18.ピュアカルチャーズ（アメリカ）
19.Dr. Eckel Animal Nutrition GmbH & Co.KG（ドイツ）
20.ユニークバイオテック社（インド）


調査対象
本レポートでは、動物用腸内環境市場を添加物、機能、供給源、家畜、形態、地域に基づいて分類しています。本レポートでは、洞察の観点から、競争環境、最終用途分析、企業プロファイルといった様々なレベルの分析に焦点を当てており、これらを合わせて、動物性腸疾患市場の新興および高成長セグメント、高成長地域、国、政府の取り組み、推進要因、阻害要因、機会、課題に関する見解を考察しています。

本レポートを購入する理由
- 動物用腸内環境改善市場の包括的な概要を把握するため。
- 業界のトップ企業、その製品ポートフォリオ、採用した主要戦略に関する幅広い情報を得ることができます。
- 動物用消化器官関連市場の主要国/地域に関する考察を得ることができます。

ページTOPに戻る


目次

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 31
1.3 STUDY SCOPE 31
FIGURE 1 MARKET SEGMENTATION 31
1.3.1 REGIONS COVERED 32
1.4 YEARS CONSIDERED 32
1.5 CURRENCY CONSIDERED 33
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019-2021 33
1.6 UNIT CONSIDERED 33
1.7 STAKEHOLDERS 33
1.8 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 ANIMAL INTESTINAL HEALTH MARKET: RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 36
2.1.2.1 Key data from primary sources 37
2.1.2.2 Breakdown of primary interviews 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION 37
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (1/2) 39
FIGURE 5 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (2/2) 40
FIGURE 6 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: DEMAND SIDE 41
2.2.1 BOTTOM-UP APPROACH 42
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 42
2.2.2 TOP-DOWN APPROACH 43
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 43
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 45
2.4.1 ASSUMPTIONS 45
2.4.2 LIMITATIONS 46
 
3 EXECUTIVE SUMMARY 47
FIGURE 10 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027 48
FIGURE 11 POULTRY SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027 48
FIGURE 12 DRY FORM SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE BY 2022 49
FIGURE 13 MICROBIAL SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SIZE BY 2027 49
FIGURE 14 ASIA PACIFIC EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 50
4 PREMIUM INSIGHTS 51
4.1 OPPORTUNITIES IN ANIMAL INTESTINAL HEALTH MARKET 51
FIGURE 15 INCREASE IN DEMAND FOR FEED AND FEED ADDITIVES DRIVING GROWTH OF ANIMAL INTESTINAL HEALTH MARKET 51
4.2 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE 51
FIGURE 16 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 51
4.3 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK AND KEY COUNTRIES 52
FIGURE 17 CHINA AND POULTRY SEGMENT EXPECTED TO ACCOUNT FOR SIGNIFICANT MARKET SHARE IN ASIA PACIFIC MARKET IN 2022 52
4.4 ANIMAL INTESTINAL HEALTH MARKET, BY FORM AND REGION 53
FIGURE 18 DRY SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE IN 2022 53
4.5 ANIMAL INTESTINAL HEALTH MARKET, BY MAJOR REGIONAL SUBMARKETS 53
FIGURE 19 CHINA EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 20 ANIMAL INTESTINAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 55
5.2.1.1 Increased production of compound feed 55
FIGURE 21 GLOBAL COMPOUND FEED PRODUCTION, 2012–2021 (MILLION METRIC TONS) 56
FIGURE 22 COMPOUND FEED PRODUCTION, BY TOP 7 COUNTRIES, 2016–2020 (MILLION METRIC TONS) 56
5.2.1.2 Rising demand for animal protein 57
TABLE 2 PER CAPITA CONSUMPTION OF LIVESTOCK PRODUCTS, BY REGION 57
5.2.1.3 Intestinal disorders among livestock 58
5.2.2 RESTRAINTS 58
5.2.2.1 Stringent regulations for use of feed additives 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Innovations and technological advancements in feed industry 59
5.2.3.2 Increased awareness about feed and food safety 59
5.2.4 CHALLENGES 60
5.2.4.1 High cost of feed additives 60
5.2.4.1.1 R&D costs associated with development of probiotics 60
5.2.4.1.2 High cost of active ingredients used in development of phytogenic feed additives 60
6 INDUSTRY TRENDS 61
6.1 INTRODUCTION 61
6.2 TRENDS IMPACTING CUSTOMERS’ BUSINESS 62
FIGURE 23 TRENDS IMPACTING ANIMAL INTESTINAL HEALTH MARKET 62
6.3 VALUE CHAIN 62
FIGURE 24 VALUE CHAIN ANALYSIS 63
6.4 TRADE ANALYSIS 64
FIGURE 25 EXPORT OF LIVESTOCK SPECIES, 2016–2021 (USD MILLION) 64
6.5 TECHNOLOGY ANALYSIS 65
6.6 PATENT ANALYSIS 65
TABLE 3 KEY PATENTS PERTAINING TO ANIMAL INTESTINAL HEALTH, 2019–2022 66
6.7 ECOSYSTEM MAP 67
6.7.1 ANIMAL INTESTINAL HEALTH MARKET: ECOSYSTEM MAP 68
FIGURE 26 FEED AND ANIMAL NUTRITION: ECOSYSTEM MAP 68
6.8 PORTER’S FIVE FORCES ANALYSIS 69
TABLE 4 PORTER’S FIVE FORCES ANALYSIS 69
6.8.1 THREAT OF NEW ENTRANTS 69
6.8.2 THREAT OF SUBSTITUTES 70
6.8.3 BARGAINING POWER OF SUPPLIERS 70
6.8.4 BARGAINING POWER OF BUYERS 70
6.8.5 INTENSITY OF COMPETITIVE RIVALRY 71
6.9 CASE STUDIES 71
6.9.1 REGULATIONS ON ANTIBIOTICS LEADING TO A SHIFT TOWARD PROBIOTICS 71
6.10 PRICING ANALYSIS 72
6.10.1 ANIMAL INTESTINAL HEALTH MARKET: AVERAGE SELLING PRICE TREND ANALYSIS 72
TABLE 5 AVERAGE SELLING PRICE, BY ADDITIVE, 2019–2027 (USD/KG) 72
6.11 REGULATORY FRAMEWORK 73
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
6.11.2 CODEX ALIMENTARIUS COMMISSION (CAC) 73
6.11.2.1 North America 73
6.11.2.2 Europe 74
6.11.2.3 Asia Pacific 75
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 76
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING ANIMAL INTESTINAL HEALTH PRODUCTS 76
TABLE 6 INFLUENCE OF STAKEHOLDERS ON TOP THREE PRODUCT TYPES 76
6.12.2 BUYING CRITERIA 77
FIGURE 28 KEY BUYING CRITERIA FOR ADDITIVES 77
TABLE 7 KEY BUYING CRITERIA FOR ADDITIVES 77
6.13 KEY CONFERENCES AND EVENTS, 2022–2023 78
TABLE 8 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF CONFERENCES & EVENTS, BY REGION, 2022–2023 78
7 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE 79
7.1 INTRODUCTION 80
FIGURE 29 PROBIOTICS SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET BY 2027 80
TABLE 9 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 81
TABLE 10 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 81
7.2 PROBIOTICS 81
7.2.1 PROBIOTIC MICROORGANISMS OFFER HEALTH BENEFITS 81
TABLE 11 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 82
TABLE 12 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 83
7.3 PREBIOTICS 83
7.3.1 PREBIOTICS INDUCE GROWTH OF BENEFICIAL GUT BACTERIA 83
7.3.1.1 Oligosaccharides 84
7.3.1.2 Inulin 84
7.3.1.3 Other additives 85
TABLE 13 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 85
TABLE 14 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 85
7.4 PHYTOGENICS 86
7.4.1 PHYTOGENIC FEED ADDITIVES OFFER MORE THAN FLAVORING PROPERTIES 86
7.4.1.1 Essential oils 86
7.4.1.2 Flavonoids 87
7.4.1.3 Saponins 87
7.4.1.4 Oleoresins 87
7.4.1.5 Other additives 87
TABLE 15 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 88
TABLE 16 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 88
7.5 IMMUNOSTIMULANTS 88
7.5.1 IMMUNOSTIMULANTS IMPROVE IMMUNITY AND REDUCE STRESS AND DISEASES IN AQUACULTURE 88
TABLE 17 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 89
TABLE 18 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 89
8 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK 90
8.1 INTRODUCTION 91
FIGURE 30 POULTRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 91
TABLE 19 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 92
TABLE 20 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 92
8.2 POULTRY 92
8.2.1 FEED ADDITIVES ENHANCE POULTRY PERFORMANCE 92
TABLE 21 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION) 93
TABLE 22 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 93
TABLE 23 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 93
8.2.1.1 Broilers 94
8.2.1.2 Layers 94
8.2.1.3 Turkey 94
8.2.1.4 Other poultry species 94
8.3 SWINE 95
8.3.1 RISE IN PORK TRADE AND CONCERNS OVER MEAT SAFETY 95
TABLE 24 PROBIOTIC MICROORGANISMS USED IN SWINE FEED 96
TABLE 25 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 96
TABLE 26 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 97
8.4 RUMINANTS 97
8.4.1 FEED ADDITIVES BOOST PRODUCTION EFFICIENCY IN RUMINANTS 97
TABLE 27 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION) 98
TABLE 28 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 98
TABLE 29 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 98
8.4.1.1 Dairy cattle 99
8.4.1.2 Beef cattle 99
8.4.1.3 Calves 99
8.4.1.4 Other ruminant species 99
8.5 AQUACULTURE 100
8.5.1 FEED ADDITIVES IMPROVE FEED QUALITY AND ENHANCE AQUACULTURE PERFORMANCE 100
TABLE 30 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 100
TABLE 31 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 101
8.6 OTHER LIVESTOCK 101
8.6.1 PHYTOGENIC-BASED ANIMAL INTESTINAL PRODUCTS IMPROVE DIGESTIBILITY IN PETS 101
TABLE 32 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 101
TABLE 33 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 102
9 ANIMAL INTESTINAL HEALTH MARKET, BY FORM 103
9.1 INTRODUCTION 104
FIGURE 31 DRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 104
TABLE 34 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 105
TABLE 35 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 105
9.2 DRY 105
9.2.1 EASE OF STORAGE AND TRANSPORTATION 105
TABLE 36 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 106
TABLE 37 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 106
9.3 LIQUID 107
9.3.1 LIQUID SUPPLEMENTS PROVIDE UNIFORM TEXTURE TO FINAL PRODUCTS 107
TABLE 38 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 108
TABLE 39 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 108
10 ANIMAL INTESTINAL HEALTH MARKET, BY FUNCTION 109
10.1 METABOLISM 109
10.1.1 ADDITIVES IMPROVE SURVIVAL AND IMPLANTATION OF LIVE MICROBIAL DIETARY SUPPLEMENTS IN GI TRACT 109
10.2 WEIGHT GAIN 109
10.2.1 FEED ADDITIVES IMPROVE PRODUCTION AND PERFORMANCE OF RUMINANTS 109
10.3 NUTRIENT DIGESTION 110
10.3.1 FEED ADDITIVES IMPROVE DIGESTIBILITY OF NUTRIENTS 110
10.4 DISEASE PREVENTION 110
10.4.1 USE OF FEED ADDITIVES PREVENTS DISEASES IN ANIMALS AND IMPROVES HEALTH 110
10.5 BONE AND JOINT HEALTH 111
10.5.1 PREBIOTICS BETTER CALCIUM METABOLISM AND BONE HEALTH 111
11 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE 112
11.1 INTRODUCTION 113
FIGURE 32 MICROBIAL SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 113
TABLE 40 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 113
TABLE 41 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 114
11.2 MICROBIAL 114
11.2.1 PROBIOTICS PREPARED USING BACILLUS SUBTILIS AND STREPTOCOCCI IMPROVE EFFICIENCY IN POULTRY AND SWINE 114
TABLE 42 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 115
TABLE 43 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 115
11.3 PLANT-BASED 116
11.3.1 PLANT-BASED SUBSTANCES IMPROVE NUTRIENT DIGESTIBILITY IN ANIMALS 116
TABLE 44 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 117
TABLE 45 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 117
12 ANIMAL INTESTINAL HEALTH MARKET, BY REGION 118
12.1 INTRODUCTION 119
FIGURE 33 INDIA EXPECTED TO WITNESS HIGH GROWTH IN ANIMAL INTESTINAL HEALTH MARKET BETWEEN 2022 AND 2027 120
TABLE 46 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 120
TABLE 47 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027(KT) 121
12.2 NORTH AMERICA 121
FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT 122
TABLE 48 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 122
TABLE 49 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 123
TABLE 50 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 123
TABLE 51 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 123
TABLE 52 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 124
TABLE 53 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 124
TABLE 54 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 124
TABLE 55 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 124
TABLE 56 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 125
12.2.1 US 125
12.2.1.1 Rise in consumption of poultry products 125
TABLE 57 US: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 126
12.2.2 CANADA 126
12.2.2.1 Food safety concerns and government regulations 126
TABLE 58 CANADA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 127
12.2.3 MEXICO 127
12.2.3.1 Rise in import of high-quality meat products 127
TABLE 59 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 127
12.3 EUROPE 128
TABLE 60 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 129
TABLE 61 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 129
TABLE 62 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 129
TABLE 63 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 130
TABLE 64 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 130
TABLE 65 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 130
TABLE 66 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 131
TABLE 67 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 131
TABLE 68 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 131
12.3.1 SPAIN 131
12.3.1.1 Increased demand for meat and dairy products 131
TABLE 69 SPAIN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 132
12.3.2 GERMANY 132
12.3.2.1 Focus on offering high-quality meat products 132
TABLE 70 GERMANY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 132
12.3.3 FRANCE 133
12.3.3.1 Rising instances of disease outbreaks 133
TABLE 71 FRANCE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 133
12.3.4 ITALY 133
12.3.4.1 Need for alternative growth promoters encourage use of probiotics 133
TABLE 72 ITALY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 134
12.3.5 UK 134
12.3.5.1 Intensive farming results in high use of premium quality nutrients in animal intestinal health products 134
TABLE 73 UK: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 134
12.3.6 REST OF EUROPE 135
12.3.6.1 Need for alternatives to antibiotic growth promoters encourage demand for phytogenics 135
TABLE 74 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 135
12.4 ASIA PACIFIC 135
FIGURE 35 ASIA PACIFIC: REGIONAL SNAPSHOT 136
TABLE 75 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 137
TABLE 76 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 137
TABLE 77 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 137
TABLE 78 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 138
TABLE 79 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 138
TABLE 80 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 138
TABLE 81 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 138
TABLE 82 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 139
TABLE 83 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 139
12.4.1 CHINA 139
12.4.1.1 High consumption of meat 139
TABLE 84 CHINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 140
12.4.2 JAPAN 140
12.4.2.1 Preference for high-quality feed products 140
TABLE 85 JAPAN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 140
12.4.3 INDIA 141
12.4.3.1 Growing demand for high-quality poultry products 141
TABLE 86 INDIA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 141
12.4.4 SOUTH KOREA 141
12.4.4.1 Increase in consumption of meat products 141
TABLE 87 SOUTH KOREA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 142
12.4.5 AUSTRALIA & NEW ZEALAND 142
12.4.5.1 High consumption of meat products 142
TABLE 88 AUSTRALIA & NEW ZEALAND: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 142
12.4.6 REST OF ASIA PACIFIC 143
12.4.6.1 Commercialization of livestock products 143
TABLE 89 REST OF ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 143
12.5 SOUTH AMERICA 143
TABLE 90 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 143
TABLE 91 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 144
TABLE 92 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 144
TABLE 93 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 144
TABLE 94 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 145
TABLE 95 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 145
TABLE 96 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 145
TABLE 97 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 145
TABLE 98 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 146
12.5.1 BRAZIL 146
12.5.1.1 High demand for meat products due to high purchasing power of people 146
TABLE 99 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 146
12.5.2 ARGENTINA 147
12.5.2.1 Growth in animal husbandry sector 147
TABLE 100 ARGENTINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 147
12.5.3 REST OF SOUTH AMERICA 147
12.5.3.1 Increased awareness among farmers about importance of feed supplements 147
TABLE 101 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 148
12.6 REST OF THE WORLD 148
TABLE 102 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 148
TABLE 103 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 149
TABLE 104 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 149
TABLE 105 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 149
TABLE 106 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 150
TABLE 107 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 150
TABLE 108 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 150
TABLE 109 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 151
TABLE 110 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 151
12.6.1 MIDDLE EAST 151
12.6.1.1 High demand for animal-based protein products 151
TABLE 111 MIDDLE EAST: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 151
12.6.2 AFRICA 152
12.6.2.1 Improvement in livestock health 152
TABLE 112 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 152
13 COMPETITIVE LANDSCAPE 153
13.1 OVERVIEW 153
13.2 MARKET EVALUATION FRAMEWORK 154
FIGURE 36 MARKET EVALUATION FRAMEWORK, 2019–2022 154
13.3 MARKET SHARE ANALYSIS 154
TABLE 113 ANIMAL INTESTINAL HEALTH MARKET SHARE ANALYSIS, 2021 155
13.4 REVENUE ANALYSIS FOR KEY COMPANIES, 2019-2021 (USD BILLION) 156
FIGURE 37 REVENUE ANALYSIS OF KEY COMPANIES, 2019-2021 (USD BILLION) 156
13.5 COMPANY EVALUATION QUADRANT 157
13.5.1 STARS 157
13.5.2 EMERGING LEADERS 157
13.5.3 PERVASIVE PLAYERS 157
13.5.4 PARTICIPANTS 157
FIGURE 38 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2021 158
13.6 STARTUP EVALUATION QUADRANT 159
13.6.1 PROGRESSIVE COMPANIES 159
13.6.2 STARTING BLOCKS 159
13.6.3 RESPONSIVE COMPANIES 159
13.6.4 DYNAMIC COMPANIES 159
FIGURE 39 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS, 2021 160
13.7 PRODUCT FOOTPRINT (KEY PLAYERS) 161
TABLE 114 COMPANY FOOTPRINT, BY LIVESTOCK 161
TABLE 115 COMPANY FOOTPRINT, BY ADDITIVE 161
TABLE 116 COMPANY FOOTPRINT, BY REGION 162
TABLE 117 OVERALL COMPANY FOOTPRINT 163
13.7.1 COMPETITIVE BENCHMARKING OF KEY PLAYERS 163
TABLE 118 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF KEY PLAYERS 163
13.7.2 COMPETITIVE BENCHMARKING OF SMES/OTHER PLAYERS 164
TABLE 119 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF SMES/OTHER PLAYERS 164
13.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 165
13.8.1 NEW PRODUCT LAUNCHES 165
TABLE 120 ANIMAL INTESTINAL HEALTH MARKET: NEW PRODUCT LAUNCHES, 2019-2021 165
13.8.2 OTHER DEVELOPMENTS 166
TABLE 121 ANIMAL INTESTINAL HEALTH MARKET: OTHER DEVELOPMENTS, 2019-2020 166
13.8.3 DEALS 167
TABLE 122 ANIMAL INTESTINAL HEALTH MARKET: DEALS, 2020-2021 167
14 COMPANY PROFILES 168
(Business overview, Products offered, Recent Developments, MNM view)*
14.1 KEY PLAYERS 168
14.1.1 ADM 168
TABLE 123 ADM: BUSINESS OVERVIEW 168
FIGURE 40 ADM: COMPANY SNAPSHOT 169
TABLE 124 ADM: PRODUCTS OFFERED 170
TABLE 125 ADM: OTHERS, 2021 170
TABLE 126 ADM: PRODUCT LAUNCHES, 2020 171
14.1.2 KONINKLIJKE DSM N.V. 172
TABLE 127 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW 172
FIGURE 41 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT 173
TABLE 128 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED 173
TABLE 129 KONINKLIJKE DSM N.V.: DEALS, 2020 174
14.1.3 DUPONT NUTRITION & BIOSCIENCES (DANISCO ANIMAL NUTRITION) 176
TABLE 130 DUPONT NUTRITION & BIOSCIENCES: BUSINESS OVERVIEW 176
FIGURE 42 DUPONT NUTRITION & BIOSCIENCES: COMPANY SNAPSHOT 177
TABLE 131 DUPONT NUTRITION & BIOSCIENCES: PRODUCTS OFFERED 177
TABLE 132 DUPONT NUTRITION & BIOSCIENCES: DEALS, 2019-2021 178
TABLE 133 DUPONT NUTRITION & BIOSCIENCES: PRODUCT LAUNCHES, 2019 178
TABLE 134 DUPONT NUTRITION & BIOSCIENCES: OTHERS, 2020 179
14.1.4 CARGILL INCORPORATED 180
TABLE 135 CARGILL INCORPORATED: BUSINESS OVERVIEW 180
FIGURE 43 CARGILL INC.: COMPANY SNAPSHOT 180
TABLE 136 CARGILL INCORPORATED: PRODUCTS OFFERED 181
TABLE 137 CARGILL INCORPORATED: DEALS, 2020 181
TABLE 138 CARGILL INCORPORATED: OTHERS, 2022 181
14.1.5 NOVOZYMES 183
TABLE 139 NOVOZYMES: BUSINESS OVERVIEW 183
FIGURE 44 NOVOZYMES: COMPANY SNAPSHOT 184
TABLE 140 NOVOZYMES: PRODUCTS OFFERED 184
TABLE 141 NOVOZYMES: DEALS, 2020 185
14.1.6 KEMIN INDUSTRIES INC. 186
TABLE 142 KEMIN INDUSTRIES INC.: BUSINESS OVERVIEW 186
TABLE 143 KEMIN INDUSTRIES INC.: PRODUCTS OFFERED 187
TABLE 144 KEMIN INDUSTRIES: PRODUCT LAUNCHES, 2020 187
14.1.7 NUTRECO 188
TABLE 145 NUTRECO: BUSINESS OVERVIEW 188
FIGURE 45 NUTRECO: COMPANY SNAPSHOT 188
TABLE 146 NUTRECO: PRODUCTS OFFERED 189
TABLE 147 NUTRECO: DEALS 2019-2020 189
14.1.8 CHR. HANSEN HOLDING A/S 191
TABLE 148 CHR. HANSEN HOLDING A/S: BUSINESS OVERVIEW 191
FIGURE 46 CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT 192
TABLE 149 CHR. HANSEN HOLDING A/S: PRODUCTS OFFERED 192
TABLE 150 CHR. HANSEN HOLDING A/S: PRODUCT LAUNCHES, 2019-2021 193
TABLE 151 CHR. HANSEN HOLDING A/S: DEALS, 2020 193
14.1.9 BLUESTAR ADISSEO CO. LTD. 195
TABLE 152 BLUESTAR ADISSEO: BUSINESS OVERVIEW 195
FIGURE 47 BLUESTAR ADISSEO CO. LTD.: COMPANY SNAPSHOT 196
TABLE 153 BLUESTAR ADISSEO CO. LTD.: PRODUCTS OFFERED 196
TABLE 154 BLUESTAR ADISSEO CO. LTD.: DEALS, 2020 197
14.1.10 ALLTECH 199
TABLE 155 ALLTECH: BUSINESS OVERVIEW 199
TABLE 156 ALLTECH: PRODUCTS OFFERED 199
14.1.11 EVONIK INDUSTRIES 201
TABLE 157 EVONIK INDUSTRIES: BUSINESS OVERVIEW 201
FIGURE 48 EVONIK INDUSTRIES: COMPANY SNAPSHOT 202
TABLE 158 EVONIK INDUSTRIES: PRODUCTS OFFERED 202
TABLE 159 EVONIK INDUSTRIES: PRODUCT LAUNCHES, 2020 203
14.1.12 LALLEMAND INC. 204
TABLE 160 LALLEMAND INC.: BUSINESS OVERVIEW 204
TABLE 161 LALLEMAND INC.: PRODUCTS OFFERED 204
TABLE 162 LALLEMAND INC.: OTHER DEVELOPMENTS, 2019-2020 205
14.1.13 BIORIGIN 206
TABLE 163 BIORIGIN: BUSINESS OVERVIEW 206
TABLE 164 BIORIGIN: PRODUCTS OFFERED 206
TABLE 165 BIORIGIN: DEALS, 2019 207
14.1.14 LAND O’LAKES 208
TABLE 166 LAND O’LAKES: BUSINESS OVERVIEW 208
FIGURE 49 LAND O’LAKES: COMPANY SNAPSHOT 208
TABLE 167 LAND O’LAKES: PRODUCTS OFFERED 209
TABLE 168 LAND O’LAKES: OTHERS, 2019 209
TABLE 169 LAND O’LAKES: DEALS, 2019 210
14.1.15 LESAFFRE 211
TABLE 170 LESAFFRE: BUSINESS OVERVIEW 211
TABLE 171 LESAFFRE: PRODUCTS OFFERED 211
TABLE 172 LESAFFRE: OTHER DEVELOPMENTS, 2019-2020 212
TABLE 173 LESAFFRE: PRODUCT LAUNCHES, 2019 212
14.1.16 CALPIS CO LTD 214
TABLE 174 CALPIS CO LTD.: BUSINESS OVERVIEW 214
14.1.17 AB VISTA 215
14.1.18 PURE CULTURES 215
14.1.19 DR. ECKEL ANIMAL NUTRITION GMBH & CO. KG 216
14.1.20 UNIQUE BIOTECH 217
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
15 ADJACENT AND RELATED MARKETS 218
15.1 INTRODUCTION 218
TABLE 175 ADJACENT MARKETS TO ANIMAL INTESTINAL HEALTH 218
15.2 LIMITATIONS 218
15.3 PHYTOGENIC FEED ADDITIVES MARKET 219
15.3.1 MARKET DEFINITION 219
15.3.2 MARKET OVERVIEW 219
TABLE 176 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2016–2019 (USD MILLION) 219
TABLE 177 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2020–2025 (USD MILLION) 220
15.4 PROBIOTICS IN ANIMAL FEED MARKET 220
15.4.1 MARKET DEFINITION 220
TABLE 178 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2017–2020 (USD MILLION) 220
TABLE 179 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2021–2026 (USD MILLION) 221
 
16 APPENDIX 222
16.1 DISCUSSION GUIDE 222
16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 226
16.3 AVAILABLE CUSTOMIZATION 228
16.4 RELATED REPORTS 229
16.5 AUTHOR DETAILS 230

　

ページTOPに戻る


　

Summary

The animal intestinal health market, estimated at USD 3.7 billion in 2022 and is projected to grow to USD 5.4 billion in 2027, at a CAGR of 8.2% from 2022 to 2027. Feed additives provide nutritional value to the regular meal consumed by animals. With the increase in population, animal intestinal feed products have also witnessed a surge in demand. To cater to the growing demand for feed products, manufacturers are focusing on utilizing probiotics, prebiotics, phytogenic feed additives, and other feed additives to enhance the gut health and productivity of livestock. The rise in awareness about meat and dairy products, health concerns related to livestock, and the increase in the industrialization of animal-processed products are the major factors driving the growth of the animal intestinal health market globally. With the imposition of regulations by government agencies on the use of antibiotics, the demand for natural feed additives to improve the quality of intestinal health products is expected to remain high.


“Europe is the second fastest growing region, projected to witness the growth of 7.62% during the forecast period in terms of volume.”
The European feed industry is one of the largest markets for feed production at a global level. European feed producers are using various feed additives based on probiotics, prebiotics, phytogenics, and immunostimulants to cater to the increase in demand for high-quality feed products for enhanced performance of livestock. Various feed producers in the region are witnessing a shift in their focus on the inclusion of prebiotics, such as mannan oligosaccharides and fructooligosaccharides, which improves performance in livestock. The European feed producers prefer using phytogenics, such as essential oils, as an alternative to feed-grade antibiotics used in pork feed production. These phytogenics act as a key feed additive, help increase feed intake and improve gut functions in the livestock.
“The microbial segment accounted for a larger market share during the forecast period”
The microbial segment accounted for a larger market share during the forecast period due to the increase in the availability of feed additives manufactured by using microorganisms. Probiotics help in weight gain, improve the digestibility of feed products, and enhance the overall gut microflora in livestock species, such as swine, ruminants, and poultry. However, with the increase in awareness about the various alternatives to microbial sources, plant-based sources of intestinal health, such as phytogenics and certain prebiotics have become popular.
“The dry form segment dominates the market with 73.64% of total market share in terms of value in 2022.”
Dry animal intestinal health products are preferred by feed manufacturers as they are relatively cheaper than their liquid counterparts. Also, it is easier to mix the powder form of different additives. The dry form has a higher shelf life and is easier to transport. All this makes it a preferred alternative among feed manufacturers and feeders.


Break-up of Primaries:
 By Company Type: Tier 1 – 60.0%, Tier 2- 25.0%, Tier 3 – 15.0%
 By Designation: Managers – 45.0%, CXOs – 35.0%, and Executives- 20.0%
 By Region: Europe - 45%, North America - 10%, Asia Pacific – 25%, South America-5%, RoW – 15%

Leading players profiled in this report:
1. Cargill, Incorporated (US)
2. Koninklijke DSM N.V. (Netherlands)
3. Archer Daniels Midland Company (US)
4. DuPont de Nemours, Inc. (US)
5. Evonik Industries (Germany)
6. Novozymes (Denmark)
7. Nutreco (Netherlands)
8. Chr. Hansen Holdings (Denmark)
9. Bluestar Adisseo Pvt Ltd. (China).
10. Alltech (US)
11. Evonik Industries (Germany)
12. Lallemand, Inc. (Canada)
13. Biorigin (Brazil)
14. Land and O’Lakes, Inc. (US)
15. Lesaffre (France)
16. Calpis Co., Ltd. (Japan)
17. AB Vista (England)
18. Pure Cultures (US)
19. Dr. Eckel Animal Nutrition GmbH & Co. KG (Germany)
20. Unique Biotech (India)


Research Coverage:
The report segments the Animal intestinal health market on the basis of Additive, Function, Source, Livestock, Form, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the Animal intestinal health market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.

Reasons to buy this report:
• To get a comprehensive overview of the Animal Intestinal Health market
• To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
• To gain insights about the major countries/regions in which the Animal Intestinal Health market market is flourishing



ページTOPに戻る


Table of Contents

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 31
1.3 STUDY SCOPE 31
FIGURE 1 MARKET SEGMENTATION 31
1.3.1 REGIONS COVERED 32
1.4 YEARS CONSIDERED 32
1.5 CURRENCY CONSIDERED 33
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019-2021 33
1.6 UNIT CONSIDERED 33
1.7 STAKEHOLDERS 33
1.8 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 ANIMAL INTESTINAL HEALTH MARKET: RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 36
2.1.2.1 Key data from primary sources 37
2.1.2.2 Breakdown of primary interviews 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION 37
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (1/2) 39
FIGURE 5 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (2/2) 40
FIGURE 6 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: DEMAND SIDE 41
2.2.1 BOTTOM-UP APPROACH 42
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 42
2.2.2 TOP-DOWN APPROACH 43
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 43
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 45
2.4.1 ASSUMPTIONS 45
2.4.2 LIMITATIONS 46
 
3 EXECUTIVE SUMMARY 47
FIGURE 10 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027 48
FIGURE 11 POULTRY SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027 48
FIGURE 12 DRY FORM SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE BY 2022 49
FIGURE 13 MICROBIAL SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SIZE BY 2027 49
FIGURE 14 ASIA PACIFIC EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 50
4 PREMIUM INSIGHTS 51
4.1 OPPORTUNITIES IN ANIMAL INTESTINAL HEALTH MARKET 51
FIGURE 15 INCREASE IN DEMAND FOR FEED AND FEED ADDITIVES DRIVING GROWTH OF ANIMAL INTESTINAL HEALTH MARKET 51
4.2 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE 51
FIGURE 16 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 51
4.3 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK AND KEY COUNTRIES 52
FIGURE 17 CHINA AND POULTRY SEGMENT EXPECTED TO ACCOUNT FOR SIGNIFICANT MARKET SHARE IN ASIA PACIFIC MARKET IN 2022 52
4.4 ANIMAL INTESTINAL HEALTH MARKET, BY FORM AND REGION 53
FIGURE 18 DRY SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE IN 2022 53
4.5 ANIMAL INTESTINAL HEALTH MARKET, BY MAJOR REGIONAL SUBMARKETS 53
FIGURE 19 CHINA EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 20 ANIMAL INTESTINAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 55
5.2.1.1 Increased production of compound feed 55
FIGURE 21 GLOBAL COMPOUND FEED PRODUCTION, 2012–2021 (MILLION METRIC TONS) 56
FIGURE 22 COMPOUND FEED PRODUCTION, BY TOP 7 COUNTRIES, 2016–2020 (MILLION METRIC TONS) 56
5.2.1.2 Rising demand for animal protein 57
TABLE 2 PER CAPITA CONSUMPTION OF LIVESTOCK PRODUCTS, BY REGION 57
5.2.1.3 Intestinal disorders among livestock 58
5.2.2 RESTRAINTS 58
5.2.2.1 Stringent regulations for use of feed additives 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Innovations and technological advancements in feed industry 59
5.2.3.2 Increased awareness about feed and food safety 59
5.2.4 CHALLENGES 60
5.2.4.1 High cost of feed additives 60
5.2.4.1.1 R&D costs associated with development of probiotics 60
5.2.4.1.2 High cost of active ingredients used in development of phytogenic feed additives 60
6 INDUSTRY TRENDS 61
6.1 INTRODUCTION 61
6.2 TRENDS IMPACTING CUSTOMERS’ BUSINESS 62
FIGURE 23 TRENDS IMPACTING ANIMAL INTESTINAL HEALTH MARKET 62
6.3 VALUE CHAIN 62
FIGURE 24 VALUE CHAIN ANALYSIS 63
6.4 TRADE ANALYSIS 64
FIGURE 25 EXPORT OF LIVESTOCK SPECIES, 2016–2021 (USD MILLION) 64
6.5 TECHNOLOGY ANALYSIS 65
6.6 PATENT ANALYSIS 65
TABLE 3 KEY PATENTS PERTAINING TO ANIMAL INTESTINAL HEALTH, 2019–2022 66
6.7 ECOSYSTEM MAP 67
6.7.1 ANIMAL INTESTINAL HEALTH MARKET: ECOSYSTEM MAP 68
FIGURE 26 FEED AND ANIMAL NUTRITION: ECOSYSTEM MAP 68
6.8 PORTER’S FIVE FORCES ANALYSIS 69
TABLE 4 PORTER’S FIVE FORCES ANALYSIS 69
6.8.1 THREAT OF NEW ENTRANTS 69
6.8.2 THREAT OF SUBSTITUTES 70
6.8.3 BARGAINING POWER OF SUPPLIERS 70
6.8.4 BARGAINING POWER OF BUYERS 70
6.8.5 INTENSITY OF COMPETITIVE RIVALRY 71
6.9 CASE STUDIES 71
6.9.1 REGULATIONS ON ANTIBIOTICS LEADING TO A SHIFT TOWARD PROBIOTICS 71
6.10 PRICING ANALYSIS 72
6.10.1 ANIMAL INTESTINAL HEALTH MARKET: AVERAGE SELLING PRICE TREND ANALYSIS 72
TABLE 5 AVERAGE SELLING PRICE, BY ADDITIVE, 2019–2027 (USD/KG) 72
6.11 REGULATORY FRAMEWORK 73
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
6.11.2 CODEX ALIMENTARIUS COMMISSION (CAC) 73
6.11.2.1 North America 73
6.11.2.2 Europe 74
6.11.2.3 Asia Pacific 75
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 76
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING ANIMAL INTESTINAL HEALTH PRODUCTS 76
TABLE 6 INFLUENCE OF STAKEHOLDERS ON TOP THREE PRODUCT TYPES 76
6.12.2 BUYING CRITERIA 77
FIGURE 28 KEY BUYING CRITERIA FOR ADDITIVES 77
TABLE 7 KEY BUYING CRITERIA FOR ADDITIVES 77
6.13 KEY CONFERENCES AND EVENTS, 2022–2023 78
TABLE 8 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF CONFERENCES & EVENTS, BY REGION, 2022–2023 78
7 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE 79
7.1 INTRODUCTION 80
FIGURE 29 PROBIOTICS SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET BY 2027 80
TABLE 9 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 81
TABLE 10 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 81
7.2 PROBIOTICS 81
7.2.1 PROBIOTIC MICROORGANISMS OFFER HEALTH BENEFITS 81
TABLE 11 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 82
TABLE 12 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 83
7.3 PREBIOTICS 83
7.3.1 PREBIOTICS INDUCE GROWTH OF BENEFICIAL GUT BACTERIA 83
7.3.1.1 Oligosaccharides 84
7.3.1.2 Inulin 84
7.3.1.3 Other additives 85
TABLE 13 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 85
TABLE 14 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 85
7.4 PHYTOGENICS 86
7.4.1 PHYTOGENIC FEED ADDITIVES OFFER MORE THAN FLAVORING PROPERTIES 86
7.4.1.1 Essential oils 86
7.4.1.2 Flavonoids 87
7.4.1.3 Saponins 87
7.4.1.4 Oleoresins 87
7.4.1.5 Other additives 87
TABLE 15 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 88
TABLE 16 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 88
7.5 IMMUNOSTIMULANTS 88
7.5.1 IMMUNOSTIMULANTS IMPROVE IMMUNITY AND REDUCE STRESS AND DISEASES IN AQUACULTURE 88
TABLE 17 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 89
TABLE 18 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 89
8 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK 90
8.1 INTRODUCTION 91
FIGURE 30 POULTRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 91
TABLE 19 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 92
TABLE 20 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 92
8.2 POULTRY 92
8.2.1 FEED ADDITIVES ENHANCE POULTRY PERFORMANCE 92
TABLE 21 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION) 93
TABLE 22 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 93
TABLE 23 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 93
8.2.1.1 Broilers 94
8.2.1.2 Layers 94
8.2.1.3 Turkey 94
8.2.1.4 Other poultry species 94
8.3 SWINE 95
8.3.1 RISE IN PORK TRADE AND CONCERNS OVER MEAT SAFETY 95
TABLE 24 PROBIOTIC MICROORGANISMS USED IN SWINE FEED 96
TABLE 25 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 96
TABLE 26 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 97
8.4 RUMINANTS 97
8.4.1 FEED ADDITIVES BOOST PRODUCTION EFFICIENCY IN RUMINANTS 97
TABLE 27 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION) 98
TABLE 28 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 98
TABLE 29 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 98
8.4.1.1 Dairy cattle 99
8.4.1.2 Beef cattle 99
8.4.1.3 Calves 99
8.4.1.4 Other ruminant species 99
8.5 AQUACULTURE 100
8.5.1 FEED ADDITIVES IMPROVE FEED QUALITY AND ENHANCE AQUACULTURE PERFORMANCE 100
TABLE 30 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 100
TABLE 31 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 101
8.6 OTHER LIVESTOCK 101
8.6.1 PHYTOGENIC-BASED ANIMAL INTESTINAL PRODUCTS IMPROVE DIGESTIBILITY IN PETS 101
TABLE 32 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 101
TABLE 33 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 102
9 ANIMAL INTESTINAL HEALTH MARKET, BY FORM 103
9.1 INTRODUCTION 104
FIGURE 31 DRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 104
TABLE 34 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 105
TABLE 35 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 105
9.2 DRY 105
9.2.1 EASE OF STORAGE AND TRANSPORTATION 105
TABLE 36 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 106
TABLE 37 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 106
9.3 LIQUID 107
9.3.1 LIQUID SUPPLEMENTS PROVIDE UNIFORM TEXTURE TO FINAL PRODUCTS 107
TABLE 38 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 108
TABLE 39 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 108
10 ANIMAL INTESTINAL HEALTH MARKET, BY FUNCTION 109
10.1 METABOLISM 109
10.1.1 ADDITIVES IMPROVE SURVIVAL AND IMPLANTATION OF LIVE MICROBIAL DIETARY SUPPLEMENTS IN GI TRACT 109
10.2 WEIGHT GAIN 109
10.2.1 FEED ADDITIVES IMPROVE PRODUCTION AND PERFORMANCE OF RUMINANTS 109
10.3 NUTRIENT DIGESTION 110
10.3.1 FEED ADDITIVES IMPROVE DIGESTIBILITY OF NUTRIENTS 110
10.4 DISEASE PREVENTION 110
10.4.1 USE OF FEED ADDITIVES PREVENTS DISEASES IN ANIMALS AND IMPROVES HEALTH 110
10.5 BONE AND JOINT HEALTH 111
10.5.1 PREBIOTICS BETTER CALCIUM METABOLISM AND BONE HEALTH 111
11 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE 112
11.1 INTRODUCTION 113
FIGURE 32 MICROBIAL SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 113
TABLE 40 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 113
TABLE 41 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 114
11.2 MICROBIAL 114
11.2.1 PROBIOTICS PREPARED USING BACILLUS SUBTILIS AND STREPTOCOCCI IMPROVE EFFICIENCY IN POULTRY AND SWINE 114
TABLE 42 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 115
TABLE 43 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 115
11.3 PLANT-BASED 116
11.3.1 PLANT-BASED SUBSTANCES IMPROVE NUTRIENT DIGESTIBILITY IN ANIMALS 116
TABLE 44 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 117
TABLE 45 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 117
12 ANIMAL INTESTINAL HEALTH MARKET, BY REGION 118
12.1 INTRODUCTION 119
FIGURE 33 INDIA EXPECTED TO WITNESS HIGH GROWTH IN ANIMAL INTESTINAL HEALTH MARKET BETWEEN 2022 AND 2027 120
TABLE 46 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 120
TABLE 47 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027(KT) 121
12.2 NORTH AMERICA 121
FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT 122
TABLE 48 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 122
TABLE 49 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 123
TABLE 50 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 123
TABLE 51 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 123
TABLE 52 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 124
TABLE 53 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 124
TABLE 54 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 124
TABLE 55 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 124
TABLE 56 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 125
12.2.1 US 125
12.2.1.1 Rise in consumption of poultry products 125
TABLE 57 US: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 126
12.2.2 CANADA 126
12.2.2.1 Food safety concerns and government regulations 126
TABLE 58 CANADA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 127
12.2.3 MEXICO 127
12.2.3.1 Rise in import of high-quality meat products 127
TABLE 59 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 127
12.3 EUROPE 128
TABLE 60 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 129
TABLE 61 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 129
TABLE 62 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 129
TABLE 63 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 130
TABLE 64 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 130
TABLE 65 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 130
TABLE 66 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 131
TABLE 67 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 131
TABLE 68 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 131
12.3.1 SPAIN 131
12.3.1.1 Increased demand for meat and dairy products 131
TABLE 69 SPAIN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 132
12.3.2 GERMANY 132
12.3.2.1 Focus on offering high-quality meat products 132
TABLE 70 GERMANY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 132
12.3.3 FRANCE 133
12.3.3.1 Rising instances of disease outbreaks 133
TABLE 71 FRANCE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 133
12.3.4 ITALY 133
12.3.4.1 Need for alternative growth promoters encourage use of probiotics 133
TABLE 72 ITALY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 134
12.3.5 UK 134
12.3.5.1 Intensive farming results in high use of premium quality nutrients in animal intestinal health products 134
TABLE 73 UK: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 134
12.3.6 REST OF EUROPE 135
12.3.6.1 Need for alternatives to antibiotic growth promoters encourage demand for phytogenics 135
TABLE 74 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 135
12.4 ASIA PACIFIC 135
FIGURE 35 ASIA PACIFIC: REGIONAL SNAPSHOT 136
TABLE 75 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 137
TABLE 76 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 137
TABLE 77 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 137
TABLE 78 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 138
TABLE 79 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 138
TABLE 80 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 138
TABLE 81 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 138
TABLE 82 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 139
TABLE 83 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 139
12.4.1 CHINA 139
12.4.1.1 High consumption of meat 139
TABLE 84 CHINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 140
12.4.2 JAPAN 140
12.4.2.1 Preference for high-quality feed products 140
TABLE 85 JAPAN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 140
12.4.3 INDIA 141
12.4.3.1 Growing demand for high-quality poultry products 141
TABLE 86 INDIA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 141
12.4.4 SOUTH KOREA 141
12.4.4.1 Increase in consumption of meat products 141
TABLE 87 SOUTH KOREA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 142
12.4.5 AUSTRALIA & NEW ZEALAND 142
12.4.5.1 High consumption of meat products 142
TABLE 88 AUSTRALIA & NEW ZEALAND: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 142
12.4.6 REST OF ASIA PACIFIC 143
12.4.6.1 Commercialization of livestock products 143
TABLE 89 REST OF ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 143
12.5 SOUTH AMERICA 143
TABLE 90 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 143
TABLE 91 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 144
TABLE 92 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 144
TABLE 93 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 144
TABLE 94 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 145
TABLE 95 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 145
TABLE 96 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 145
TABLE 97 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 145
TABLE 98 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 146
12.5.1 BRAZIL 146
12.5.1.1 High demand for meat products due to high purchasing power of people 146
TABLE 99 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 146
12.5.2 ARGENTINA 147
12.5.2.1 Growth in animal husbandry sector 147
TABLE 100 ARGENTINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 147
12.5.3 REST OF SOUTH AMERICA 147
12.5.3.1 Increased awareness among farmers about importance of feed supplements 147
TABLE 101 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 148
12.6 REST OF THE WORLD 148
TABLE 102 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 148
TABLE 103 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 149
TABLE 104 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 149
TABLE 105 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 149
TABLE 106 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 150
TABLE 107 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 150
TABLE 108 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 150
TABLE 109 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 151
TABLE 110 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 151
12.6.1 MIDDLE EAST 151
12.6.1.1 High demand for animal-based protein products 151
TABLE 111 MIDDLE EAST: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 151
12.6.2 AFRICA 152
12.6.2.1 Improvement in livestock health 152
TABLE 112 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 152
13 COMPETITIVE LANDSCAPE 153
13.1 OVERVIEW 153
13.2 MARKET EVALUATION FRAMEWORK 154
FIGURE 36 MARKET EVALUATION FRAMEWORK, 2019–2022 154
13.3 MARKET SHARE ANALYSIS 154
TABLE 113 ANIMAL INTESTINAL HEALTH MARKET SHARE ANALYSIS, 2021 155
13.4 REVENUE ANALYSIS FOR KEY COMPANIES, 2019-2021 (USD BILLION) 156
FIGURE 37 REVENUE ANALYSIS OF KEY COMPANIES, 2019-2021 (USD BILLION) 156
13.5 COMPANY EVALUATION QUADRANT 157
13.5.1 STARS 157
13.5.2 EMERGING LEADERS 157
13.5.3 PERVASIVE PLAYERS 157
13.5.4 PARTICIPANTS 157
FIGURE 38 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2021 158
13.6 STARTUP EVALUATION QUADRANT 159
13.6.1 PROGRESSIVE COMPANIES 159
13.6.2 STARTING BLOCKS 159
13.6.3 RESPONSIVE COMPANIES 159
13.6.4 DYNAMIC COMPANIES 159
FIGURE 39 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS, 2021 160
13.7 PRODUCT FOOTPRINT (KEY PLAYERS) 161
TABLE 114 COMPANY FOOTPRINT, BY LIVESTOCK 161
TABLE 115 COMPANY FOOTPRINT, BY ADDITIVE 161
TABLE 116 COMPANY FOOTPRINT, BY REGION 162
TABLE 117 OVERALL COMPANY FOOTPRINT 163
13.7.1 COMPETITIVE BENCHMARKING OF KEY PLAYERS 163
TABLE 118 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF KEY PLAYERS 163
13.7.2 COMPETITIVE BENCHMARKING OF SMES/OTHER PLAYERS 164
TABLE 119 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF SMES/OTHER PLAYERS 164
13.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 165
13.8.1 NEW PRODUCT LAUNCHES 165
TABLE 120 ANIMAL INTESTINAL HEALTH MARKET: NEW PRODUCT LAUNCHES, 2019-2021 165
13.8.2 OTHER DEVELOPMENTS 166
TABLE 121 ANIMAL INTESTINAL HEALTH MARKET: OTHER DEVELOPMENTS, 2019-2020 166
13.8.3 DEALS 167
TABLE 122 ANIMAL INTESTINAL HEALTH MARKET: DEALS, 2020-2021 167
14 COMPANY PROFILES 168
(Business overview, Products offered, Recent Developments, MNM view)*
14.1 KEY PLAYERS 168
14.1.1 ADM 168
TABLE 123 ADM: BUSINESS OVERVIEW 168
FIGURE 40 ADM: COMPANY SNAPSHOT 169
TABLE 124 ADM: PRODUCTS OFFERED 170
TABLE 125 ADM: OTHERS, 2021 170
TABLE 126 ADM: PRODUCT LAUNCHES, 2020 171
14.1.2 KONINKLIJKE DSM N.V. 172
TABLE 127 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW 172
FIGURE 41 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT 173
TABLE 128 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED 173
TABLE 129 KONINKLIJKE DSM N.V.: DEALS, 2020 174
14.1.3 DUPONT NUTRITION & BIOSCIENCES (DANISCO ANIMAL NUTRITION) 176
TABLE 130 DUPONT NUTRITION & BIOSCIENCES: BUSINESS OVERVIEW 176
FIGURE 42 DUPONT NUTRITION & BIOSCIENCES: COMPANY SNAPSHOT 177
TABLE 131 DUPONT NUTRITION & BIOSCIENCES: PRODUCTS OFFERED 177
TABLE 132 DUPONT NUTRITION & BIOSCIENCES: DEALS, 2019-2021 178
TABLE 133 DUPONT NUTRITION & BIOSCIENCES: PRODUCT LAUNCHES, 2019 178
TABLE 134 DUPONT NUTRITION & BIOSCIENCES: OTHERS, 2020 179
14.1.4 CARGILL INCORPORATED 180
TABLE 135 CARGILL INCORPORATED: BUSINESS OVERVIEW 180
FIGURE 43 CARGILL INC.: COMPANY SNAPSHOT 180
TABLE 136 CARGILL INCORPORATED: PRODUCTS OFFERED 181
TABLE 137 CARGILL INCORPORATED: DEALS, 2020 181
TABLE 138 CARGILL INCORPORATED: OTHERS, 2022 181
14.1.5 NOVOZYMES 183
TABLE 139 NOVOZYMES: BUSINESS OVERVIEW 183
FIGURE 44 NOVOZYMES: COMPANY SNAPSHOT 184
TABLE 140 NOVOZYMES: PRODUCTS OFFERED 184
TABLE 141 NOVOZYMES: DEALS, 2020 185
14.1.6 KEMIN INDUSTRIES INC. 186
TABLE 142 KEMIN INDUSTRIES INC.: BUSINESS OVERVIEW 186
TABLE 143 KEMIN INDUSTRIES INC.: PRODUCTS OFFERED 187
TABLE 144 KEMIN INDUSTRIES: PRODUCT LAUNCHES, 2020 187
14.1.7 NUTRECO 188
TABLE 145 NUTRECO: BUSINESS OVERVIEW 188
FIGURE 45 NUTRECO: COMPANY SNAPSHOT 188
TABLE 146 NUTRECO: PRODUCTS OFFERED 189
TABLE 147 NUTRECO: DEALS 2019-2020 189
14.1.8 CHR. HANSEN HOLDING A/S 191
TABLE 148 CHR. HANSEN HOLDING A/S: BUSINESS OVERVIEW 191
FIGURE 46 CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT 192
TABLE 149 CHR. HANSEN HOLDING A/S: PRODUCTS OFFERED 192
TABLE 150 CHR. HANSEN HOLDING A/S: PRODUCT LAUNCHES, 2019-2021 193
TABLE 151 CHR. HANSEN HOLDING A/S: DEALS, 2020 193
14.1.9 BLUESTAR ADISSEO CO. LTD. 195
TABLE 152 BLUESTAR ADISSEO: BUSINESS OVERVIEW 195
FIGURE 47 BLUESTAR ADISSEO CO. LTD.: COMPANY SNAPSHOT 196
TABLE 153 BLUESTAR ADISSEO CO. LTD.: PRODUCTS OFFERED 196
TABLE 154 BLUESTAR ADISSEO CO. LTD.: DEALS, 2020 197
14.1.10 ALLTECH 199
TABLE 155 ALLTECH: BUSINESS OVERVIEW 199
TABLE 156 ALLTECH: PRODUCTS OFFERED 199
14.1.11 EVONIK INDUSTRIES 201
TABLE 157 EVONIK INDUSTRIES: BUSINESS OVERVIEW 201
FIGURE 48 EVONIK INDUSTRIES: COMPANY SNAPSHOT 202
TABLE 158 EVONIK INDUSTRIES: PRODUCTS OFFERED 202
TABLE 159 EVONIK INDUSTRIES: PRODUCT LAUNCHES, 2020 203
14.1.12 LALLEMAND INC. 204
TABLE 160 LALLEMAND INC.: BUSINESS OVERVIEW 204
TABLE 161 LALLEMAND INC.: PRODUCTS OFFERED 204
TABLE 162 LALLEMAND INC.: OTHER DEVELOPMENTS, 2019-2020 205
14.1.13 BIORIGIN 206
TABLE 163 BIORIGIN: BUSINESS OVERVIEW 206
TABLE 164 BIORIGIN: PRODUCTS OFFERED 206
TABLE 165 BIORIGIN: DEALS, 2019 207
14.1.14 LAND O’LAKES 208
TABLE 166 LAND O’LAKES: BUSINESS OVERVIEW 208
FIGURE 49 LAND O’LAKES: COMPANY SNAPSHOT 208
TABLE 167 LAND O’LAKES: PRODUCTS OFFERED 209
TABLE 168 LAND O’LAKES: OTHERS, 2019 209
TABLE 169 LAND O’LAKES: DEALS, 2019 210
14.1.15 LESAFFRE 211
TABLE 170 LESAFFRE: BUSINESS OVERVIEW 211
TABLE 171 LESAFFRE: PRODUCTS OFFERED 211
TABLE 172 LESAFFRE: OTHER DEVELOPMENTS, 2019-2020 212
TABLE 173 LESAFFRE: PRODUCT LAUNCHES, 2019 212
14.1.16 CALPIS CO LTD 214
TABLE 174 CALPIS CO LTD.: BUSINESS OVERVIEW 214
14.1.17 AB VISTA 215
14.1.18 PURE CULTURES 215
14.1.19 DR. ECKEL ANIMAL NUTRITION GMBH & CO. KG 216
14.1.20 UNIQUE BIOTECH 217
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
15 ADJACENT AND RELATED MARKETS 218
15.1 INTRODUCTION 218
TABLE 175 ADJACENT MARKETS TO ANIMAL INTESTINAL HEALTH 218
15.2 LIMITATIONS 218
15.3 PHYTOGENIC FEED ADDITIVES MARKET 219
15.3.1 MARKET DEFINITION 219
15.3.2 MARKET OVERVIEW 219
TABLE 176 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2016–2019 (USD MILLION) 219
TABLE 177 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2020–2025 (USD MILLION) 220
15.4 PROBIOTICS IN ANIMAL FEED MARKET 220
15.4.1 MARKET DEFINITION 220
TABLE 178 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2017–2020 (USD MILLION) 220
TABLE 179 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2021–2026 (USD MILLION) 221
 
16 APPENDIX 222
16.1 DISCUSSION GUIDE 222
16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 226
16.3 AVAILABLE CUSTOMIZATION 228
16.4 RELATED REPORTS 229
16.5 AUTHOR DETAILS 230

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（加工食品）の最新刊レポート

MarketsandMarkets社の加工食品分野での最新刊レポート

本レポートと同じKEY WORD（additive）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.